CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children — ceVUS

Vesico-Ureteral Reflux Clinical Trial

Official title:
Contrast Enhanced Voiding Urosonography (ceVUS) With the Intravesical Administration of the Ultrasound Contrast Agent OPTISON TM (Trademark) for Vesicoureteral Reflux Detection and Urethral Imaging in Children.

Status Completed

Clinical Trial Summary

In this clinical trial the investigators aim to evaluate the diagnostic feasibility and safety of ceVUS with the intravesical use of OPTISON for vesicoureteral reflux detection and urethral imaging in children.

Clinical Trial Description

Contrast enhanced Voiding Urosonography (ceVUS) is a radiation free, highly sensitive imaging modality for vesicoureteral reflux (VUR) and urethral imaging in children. It employs ultrasound technology in combination with ultrasound contrast agent, which is administered intravesically via a bladder catheter. Currently, second generation ultrasound contrast agents are commercially available, comprising of gas-filled microbubbles. CeVUS in children is being widely practiced, primarily in Europe, despite the fact that none of the commercially available ultrasound contrast agents are yet approved for clinical applications in pediatric population. In the United States, there is limited clinical experience with ceVUS in children. Among the currently commercially available ultrasound contrast agents, OPTISON has already been used in research and off-label in clinical settings involving adults and children. One in-vitro study has been conducted aiming to optimize the ultrasound technical parameters and the dose of OPTISON for intravesical administration in children. In this clinical trial the investigators aim to evaluate the diagnostic feasibility and safety of ceVUS with the intravesical use of OPTISON for vesicoureteral reflux detection and urethral imaging in children. ;

Study Design

Related Conditions & MeSH terms

Vesico-Ureteral Reflux

Clinical Trial Details

NCT number	NCT02204917
Study type	Interventional
Source	Children's Hospital of Philadelphia
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	July 2014
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02271035` - A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children	Phase 4
Not yet recruiting	`NCT03653702` - Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)	Phase 1
Completed	`NCT04798443` - Endoscopic Injection of Dextranomer/Hyaluronic Acid Versus Ureteral Reimplantation In Treatment of Vesicoureteral Reflux	N/A
Completed	`NCT05864131` - Effects of Parental Holding on Pain Response in Young Children During Cystometry	N/A
Completed	`NCT01297673` - Reflux in Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction	N/A
Recruiting	`NCT00367159` - Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children	Phase 3
Withdrawn	`NCT02986477` - Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration	N/A
Active, not recruiting	`NCT04251988` - VR to Reduce Pain and Anxiety During GU Scans	N/A